Arbutus Biopharma
- Market cap
- 849.87M
- P/E (TTM)i
- 5.43
- P/Bi
- 3.28
- EPSi
- -0.17
- Div yieldi
- 0.00%
- 52W posi
- 41%
Anonymous reader poll. Unscientific, not investment advice.
Arbutus Biopharma shares were changing hands at 4.29, down 4.24% on the day. That leaves the company valued at approximately 849.87M, the #3365 most valuable US-listed company we track. Over the past year the stock has ranged from 3.50 to 5.45; it now sits 41% up that band.
✦ StockVane Quant Insights how this is computed
- Not yet in the StockVane Momentum strategy's universe - this name needs price history back to 2021 for a reliable signal and doesn't have it yet (most often because it IPO'd or was spun off more recently). This grade is a preliminary blend of valuation, momentum and analyst data, not a Momentum buy/sell call.
- Valuation sits at the 47% percentile of its own 5-year range.
- Price momentum averages -8.6% across the trailing 3-month/1-year windows.
- Recent price momentum is -8.6% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 9.3% of float.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 4.48
- Open
- 4.46
- Day range
- 4.28 - 4.48
- Avg price
- 4.33
- Volume
- 4.79M
- Turnover
- 20.74M
- Turnover ratei
- 3.91%
- Volume ratioi
- 0.42
- Amplitudei
- 4.46%
- 52-week rangei
- 3.50 - 5.45
Valuation
- P/Ei
- -25.24
- P/E (TTM)i
- 5.43
- P/Bi
- 3.28
- EPSi
- -0.17
- Book value / shi
- 1.31
- Net profit
- -33.68M
- Net assets
- 258.73M
Share structure
- Market cap
- 849.87M
- Float capi
- 526.05M
- Shares out
- 198.11M
- Float sharesi
- 122.62M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2015-05-04
21.3% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-31.66M net over the window
Short interest
- Shares short
- 18.48M
- % of floati
- 9.33%
- Days to coveri
- 5.01
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Arbutus Biopharma (ABUS)?
Arbutus Biopharma last traded at 4.29. The quote on this page refreshes every few seconds while US markets are open.
What is Arbutus Biopharma's market cap?
About 849.87M.
What is the P/E ratio of Arbutus Biopharma?
The trailing twelve-month P/E is 5.43. The Valuation tab shows it against the stock's own five-year range.
Does Arbutus Biopharma pay a dividend?
Arbutus Biopharma does not currently pay a regular dividend.
Quote time 2026-10-08 08:13:13 · For reference only, not investment advice and not tailored to your situation.